BioCatalyst

Autologous genetically modified gamma-delta T cells, Allogeneic genetically modified gamma-delta T cells — catalyst calendar

1 verified catalyst event(s) referencing Autologous genetically modified gamma-delta T cells, Allogeneic genetically modified gamma-delta T cells, each linked to its official source. Verified as of 2026-11-05.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12 (month)
in 26d
ESTIMATED
 READOUT
A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Alloge
Phase 1/2 · Glioblastoma
 INAB IN8BIO, INC. Autologous genetically modified gamma-de ClinicalTrials.gov ↗
✓ Source-checked 2026-11-05
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.